Throughout the last three months, 7 analysts have evaluated Eastman Chemical EMN, offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 3 | 4 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 1 | 2 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 2 | 1 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Eastman Chemical, presenting an average target of $90.86, a high estimate of $101.00, and a low estimate of $78.00. Surpassing the previous average price target of $87.83, the current average has increased by 3.45%.
Interpreting Analyst Ratings: A Closer Look
The standing of Eastman Chemical among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Joshua Spector | UBS | Raises | Neutral | $91.00 | $89.00 |
Aleksey Yefremov | Keybanc | Raises | Overweight | $101.00 | $95.00 |
Joshua Spector | UBS | Raises | Neutral | $89.00 | $81.00 |
Duffy Fischer | Goldman Sachs | Raises | Neutral | $92.00 | $82.00 |
Frank Mitsch | Fermium Research | Lowers | Hold | $78.00 | $82.00 |
Jeffrey Zekaukas | JP Morgan | Announces | Overweight | $90.00 | - |
Aleksey Yefremov | Keybanc | Lowers | Overweight | $95.00 | $98.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Eastman Chemical. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Eastman Chemical compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Eastman Chemical's stock. This comparison reveals trends in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Eastman Chemical's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Eastman Chemical analyst ratings.
Unveiling the Story Behind Eastman Chemical
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemicals company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
Eastman Chemical: Delving into Financials
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Eastman Chemical's revenue growth over 3 months faced difficulties. As of 30 September, 2023, the company experienced a decline of approximately -16.32%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Eastman Chemical's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.85% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Eastman Chemical's ROE excels beyond industry benchmarks, reaching 3.35%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Eastman Chemical's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.21%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 0.98, Eastman Chemical faces challenges in effectively managing its debt levels, indicating potential financial strain.
The Core of Analyst Ratings: What Every Investor Should Know
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.